Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 Q2- Text added to 2017 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
alleged, announce, announced, Antigen, arm, attack, body, bringing, care, cell, Chimeric, contact, cytotoxic, Department, dissemination, dosage, efficacy, Epidemiology, epithelial, exhibited, exposure, fewer, foundational, genetically, growth, Hall, Head, Hospital, immunology, insignificant, Institutet, Karolinska, Legislation, lotion, lymph, lymphatic, malignant, mandate, Maxim, MBD, MD, menopausal, met, metabolism, migrating, migration, nausea, notified, partnership, proliferation, range, rare, readIn, Receptor, regional, remanding, route, Sept, sought, South, Stockholm, supplement, Sweden, Swedish, toxicity, transdermal, transformation, transpapillary, TRAP, undergoing, vary, world
Valuein 2017 Q2 filing- Value in 2017 Q3 filing
Original filings
Filing view